These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 24331265

  • 1. Recurrent thyroid cancer diagnosis: ROC study of the effect of a high-resolution head and neck 18F-FDG PET/CT scan.
    Chatziioannou SN, Georgakopoulos AT, Pianou NK, Kafiri GT, Pavlou SN, Kallergi M.
    Acad Radiol; 2014 Jan; 21(1):58-63. PubMed ID: 24331265
    [Abstract] [Full Text] [Related]

  • 2. CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve.
    Kruse V, Van de Wiele C, Borms M, Maes A, Pottel H, Sathekge M, Cocquyt V.
    Nuklearmedizin; 2014 Aug 06; 53(4):131-8. PubMed ID: 25100557
    [Abstract] [Full Text] [Related]

  • 3. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A, Kalinyak JE, McDougall IR.
    Clin Nucl Med; 2007 Sep 06; 32(9):690-5. PubMed ID: 17710020
    [Abstract] [Full Text] [Related]

  • 4. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.
    Ann Surg Oncol; 2008 Jan 06; 15(1):286-92. PubMed ID: 17882493
    [Abstract] [Full Text] [Related]

  • 5. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S.
    J Med Imaging Radiat Oncol; 2013 Jun 06; 57(3):297-305. PubMed ID: 23721138
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Positron emission tomography-computed tomography with (18)F-fluorodeoxyglucose in patients with recurrent differentiated thyroid carcinoma and negative radioiodine scan. Diagnostic performance and relation with tyroglobulin levels].
    Mariscal Labrador E, García Burillo A, Castell-Conesa J, Obiols Alfonso G, Kisiel González N, Barios Profitós M, Aguadé-Bruix S, Mesa Manteca J.
    Rev Esp Med Nucl Imagen Mol; 2013 Jun 06; 32(3):146-51. PubMed ID: 22726673
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
    Plaza MJ, Collado-Mesa F, Bokhoor J, Alperin N, Yepes MM.
    Breast J; 2014 Jun 06; 20(3):235-42. PubMed ID: 24750508
    [Abstract] [Full Text] [Related]

  • 10. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 06; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, Kim YK.
    Nucl Med Commun; 2013 Sep 06; 34(9):868-76. PubMed ID: 23797273
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
    Nakamoto Y, Sakamoto S, Okada T, Senda M, Higashi T, Saga T, Togashi K.
    AJR Am J Roentgenol; 2007 Jan 06; 188(1):257-67. PubMed ID: 17179375
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer.
    Hebel CB, Behrendt FF, Heinzel A, Krohn T, Mottaghy FM, Bauerschlag DO, Verburg FA.
    Eur J Radiol; 2014 Mar 06; 83(3):463-7. PubMed ID: 24368010
    [Abstract] [Full Text] [Related]

  • 15. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
    Li S, Zhao B, Wang X, Yu J, Yan S, Lv C, Yang Y.
    Clin Radiol; 2014 Aug 06; 69(8):e352-7. PubMed ID: 24877581
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF.
    J Nucl Med; 2005 Jul 06; 46(7):1136-43. PubMed ID: 16000282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.
    Nucl Med Commun; 2011 Dec 06; 32(12):1162-8. PubMed ID: 21946617
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.